Oric Pharmaceuticals

ORICNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.313 B

$12.67 -0.94%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$129.5M

Loss-making

Shares outstanding

103,652,656

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#139Lb PharmaceuticalsLBRX$1.39B
#140OmerosOMER$1.34B
#141Oric PharmaceuticalsORIC$1.31B
#142HarrowHROW$1.27B
#143Opko HealthOPK$1.26B

What if Oric Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$292,072.15

Per share 23,052× higher

Bitcoin $1.72T

$16,591.99

Per share 1,310× higher

Nvidia $5.48T

$52,867.51

Per share 4,173× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Oric Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.